BIOCON.NSBIOCON.NSNSE
Loading
Operating Income ContractionContracting
Percentile Rank73
3Y CAGR-13.3%
5Y CAGR-3.5%
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

3Y CAGR
-13.3%/yr
vs +13.6%/yr prior
5Y CAGR
-3.5%/yr
Recent deceleration
Acceleration
-26.9pp
Decelerating
Percentile
P73
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$21.72B-54.0%
2025$47.20B-7.1%
2024$50.83B+52.6%
2023$33.30B+66.1%
2022$20.04B-22.8%
2021$25.98B+57.2%
2020$16.52B-17.4%
2019$19.99B+71.5%
2018$11.66B-9.3%
2017$12.86B-